NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
NeuroPace (NPCE), a medical device company specializing in epilepsy treatment, has announced its upcoming financial results release for Q4 and full-year 2024. The results will be disclosed after market close on March 4, 2025. The company will host a conference call at 1:30 PM Pacific Time / 4:30 PM Eastern Time on the same day.
Investors can access the live webcast and participate in the call via telephone by dialing +1-877-407-3982 with Conference ID 13751530. The webcast recording will be available for at least 90 days on the company's investor relations website.
NeuroPace (NPCE), un'azienda di dispositivi medici specializzata nel trattamento dell'epilessia, ha annunciato il rilascio dei risultati finanziari per il quarto trimestre e per l'intero anno 2024. I risultati saranno resi noti dopo la chiusura del mercato il 4 marzo 2025. L'azienda ospiterà una conferenza telefonica alle 1:30 PM ora del Pacifico / 4:30 PM ora dell'Est dello stesso giorno.
Gli investitori possono accedere alla diretta web e partecipare alla chiamata tramite telefono componendo il numero +1-877-407-3982 con l'ID Conferenza 13751530. La registrazione della web diretta sarà disponibile per almeno 90 giorni sul sito web delle relazioni con gli investitori dell'azienda.
NeuroPace (NPCE), una empresa de dispositivos médicos especializada en el tratamiento de la epilepsia, ha anunciado la próxima publicación de sus resultados financieros para el cuarto trimestre y el año completo 2024. Los resultados se darán a conocer después del cierre del mercado el 4 de marzo de 2025. La empresa llevará a cabo una conferencia telefónica a las 1:30 PM hora del Pacífico / 4:30 PM hora del Este el mismo día.
Los inversores pueden acceder a la transmisión en vivo y participar en la llamada por teléfono marcando +1-877-407-3982 con el ID de Conferencia 13751530. La grabación de la transmisión estará disponible durante al menos 90 días en el sitio web de relaciones con los inversores de la empresa.
NeuroPace (NPCE)는 간질 치료를 전문으로 하는 의료 기기 회사로, 2024년 4분기 및 연간 재무 결과 발표를 예정하고 있다고 발표했습니다. 결과는 2025년 3월 4일 시장 마감 후에 발표될 예정입니다. 회사는 같은 날 태평양 표준시 오후 1:30 / 동부 표준시 오후 4:30에 컨퍼런스 콜을 개최할 것입니다.
투자자는 +1-877-407-3982로 전화하여 회의 ID 13751530을 입력하여 실시간 웹캐스트에 접속하고 통화에 참여할 수 있습니다. 웹캐스트 녹화는 회사의 투자자 관계 웹사이트에서 최소 90일 동안 이용 가능할 것입니다.
NeuroPace (NPCE), une entreprise de dispositifs médicaux spécialisée dans le traitement de l'épilepsie, a annoncé la publication prochaine de ses résultats financiers pour le quatrième trimestre et l'année complète 2024. Les résultats seront divulgués après la clôture du marché le 4 mars 2025. L'entreprise animera une conférence téléphonique le même jour à 13h30 heure du Pacifique / 16h30 heure de l'Est.
Les investisseurs peuvent accéder au webinaire en direct et participer à l'appel par téléphone en composant le +1-877-407-3982 avec l'ID de conférence 13751530. L'enregistrement du webinaire sera disponible pendant au moins 90 jours sur le site web des relations avec les investisseurs de l'entreprise.
NeuroPace (NPCE), ein Unternehmen für medizinische Geräte, das sich auf die Behandlung von Epilepsie spezialisiert hat, hat die bevorstehende Veröffentlichung seiner finanziellen Ergebnisse für das vierte Quartal und das Gesamtjahr 2024 angekündigt. Die Ergebnisse werden nach Börsenschluss am 4. März 2025 veröffentlicht. Das Unternehmen wird am selben Tag um 13:30 Uhr Pazifischer Zeit / 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten.
Investoren können auf das Live-Webcast zugreifen und an dem Anruf teilnehmen, indem sie +1-877-407-3982 mit der Konferenz-ID 13751530 wählen. Die Aufzeichnung des Webcasts wird mindestens 90 Tage lang auf der Website für Investor Relations des Unternehmens verfügbar sein.
- None.
- None.
MOUNTAIN VIEW, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and full year of 2024 after market close on Tuesday, March 4, 2025. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https://viavid.webcasts.com/starthere.jsp?ei=1706647&tp_key=43fdbb668b. Individuals interested in participating in the call via telephone may access the call by dialing +1-877-407-3982 and referencing Conference ID 13751530. The webcast will be archived on the company’s investor relations website at https://investors.neuropace.com/news-and-events/events and will be available for replay for at least 90 days after the event.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com
FAQ
When will NeuroPace (NPCE) release its Q4 and full-year 2024 earnings?
How can investors access NPCE's Q4 2024 earnings call?
What time is NeuroPace's (NPCE) Q4 2024 earnings call?
How long will NPCE's Q4 2024 earnings call recording be available?
